In Brief: Device corrections and removals reg
This article was originally published in The Gray Sheet
Device corrections and removals reg: Effective date of the regulation will be stayed indefinitely pending Office of Management and Budget completion of the information collection requirements, FDA says in a Dec. 24 Federal Register notice. The reg, which requires manufacturers to report device recalls to FDA ("The Gray Sheet" May 26, p. 8), originally was slated to go into effect Nov. 17...
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.